SAN DIEGO — Cypher Genomics, Inc., a leading genome informatics company, today announced a collaboration with Celgene Corporation to apply Cypher’s CoralTM technology to discover novel genomic biomarkers that associate with patient response to innovative medicines. The information generated from the collaboration is intended to help accelerate patient access to the right medicine at the […]
Denali Therapeutics Inc. (“Denali”), a new biotechnology company focused on developing effective therapies for neurodegenerative diseases, announced today that it has launched with an initial investment commitment of $217 million. Denali is based on the collaboration of world-class scientists, industry experts and investors. Recent scientific insights into the genetic causes and biological processes underlying neurodegenerative […]
Singapore — SCIEX, a global leader in life science analytical technologies, and the Protein and Proteomics Centre (PPC) under the Department of Biological Sciences of the National University of Singapore’s (NUS) Faculty of Science, announced they have signed a Memorandum of Understanding (MOU) to promote joint research and development activities in oncology biomarker discovery and […]
SAN DIEGO — Illumina (NASDAQ:ILMN) announced today that the company has filed a new patent infringement suit against Ariosa Diagnostics, Inc. and its parent company, Roche Molecular Systems, Inc. Illumina is seeking all available remedies. The new suit, filed in the U.S. District Court for the Northern District of California, is based on Ariosa’s infringement […]
SANTA CLARA, Calif. — Affymetrix (NASDAQ: AFFX) today announced that Riccardo Pigliucci has been appointed to the company’s board of directors effective May 13, 2015. Mr. Pigliucci will serve as a member of the Compensation Committee. Mr. Pigliucci has served as the Managing Partner of Aldwych Associates, LLP, a management and technology consulting partnership since […]
SEATTLE — NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies through its MolDx program, has issued a favorable draft local coverage determination (LCD) for the Prosigna Breast Cancer Assay. “We are […]
LEXINGTON, Mass. -– N-of-One, Inc. , the leading provider of clinical interpretation evidence, today announced that CellNetix Pathology and Laboratories has adopted N-of-One’s new clinical trial matching solution, TrialMatch™, as well as N-of-One clinical interpretation evidence services. Under this agreement, N-of-One will provide industry-leading clinical interpretation evidence as well as molecular profile-based clinical trial matching […]
San Diego — GenomeDx Biosciences today announced the launch of the Decipher® Genomics Resource Information Database (Decipher GRIDTM), a clinical genomics data sharing program that unites patient registries from leading cancer centers with GenomeDx’s full genome profiling platform. The Sidney Kimmel Cancer Center at Thomas Jefferson University is the first institution to partner with GenomeDx […]
Cambridge, UK — Horizon Discovery Group plc (LSE:HZD) (Horizon), the international life science company supplying research tools and services that power genomics research and the development of personalized medicines, today announced it has introduced a unique range of genetically defined, highly characterized HDx Reference Standards for Immunohistochemistry (IHC) assays. The product range has been developed […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II Sequencing System, today announced that it has achieved a second development milestone under its development, commercialization and license agreement with F. Hoffman-La Roche Ltd (Roche), earning an additional $10 million. The development, commercialization and license agreement with Roche covers […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
